Is CEVA (CEVA) Above Fair Value After a 73% Rally?

CEVA, Inc.

CEVA, Inc.

CEVA

0.00

CEVA stock has rallied strongly this year, yet the broad valuation checks still lean cautious, creating a gap between its recent share price strength and what the numbers suggest about how comfortably priced it is.

  • CEVA is up 72.9% year to date, a jump that puts recent momentum front and center in any valuation discussion.
  • For a semiconductor licensing business like CEVA, expectations for sustained royalty and licensing revenue can support higher multiples, while any pressure on customer demand or design wins may quickly challenge those assumptions.
  • CEVA currently passes only 2 of 6 valuation checks, which points to a stock that is not a clear bargain on the broader assessment.

The issue now is whether CEVA's strong share price run still leaves enough valuation support for investors who are looking at the stock today.

Does CEVA Look Undervalued on Sales?

The P/S multiple is a useful way to look at CEVA because licensing and royalty businesses are often judged on revenue rather than current earnings. CEVA trades on a P/S of about 9.6x, which is higher than the broader semiconductor industry average of 7.6x and well above the peer group average of roughly 2.6x. On simple comparisons, that places CEVA at a premium to many listed semiconductor stocks.

However, Simply Wall St’s fair P/S estimate for CEVA is around 10.9x, which is higher than where the stock is currently priced. That suggests the current market value sits below the level implied by its own mix of growth prospects, margins, size and risk profile, even after the strong share price move this year.

On this P/S framework, CEVA stock currently appears undervalued relative to the fair multiple implied by its fundamentals.

NasdaqGS:CEVA P/S Ratio as at Jul 2026
NasdaqGS:CEVA P/S Ratio as at Jul 2026

The CEVA Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for CEVA pick up where this valuation puzzle leaves off by spelling out the specific growth, margin and earnings paths that would need to play out for CEVA's stock to be worth materially more or less than it is today. They sit on the company’s Community page as clear scenarios you can revisit over time as fresh information comes in and as the balance of growth, profitability and risk evolves.

The community is split on CEVA, with one camp focusing on Edge AI upside and another worrying about how fragile the licensing model might be.

Bull case: 21% undervalued

"Deepening relationships with top-tier semiconductor and OEM customers (such as the multi-IP agreements with high-volume connectivity companies and expanded partnerships with Qualcomm post-Autotalks acquisition) increase revenue visibility, drive cross-selling, and strengthen CEVA's position in securing recurring, higher-margin royalty flows…"

Bear case: 8% overvalued

"As global technology giants increasingly prioritize designing their own proprietary chips to differentiate and control their product roadmaps, CEVA faces a serious erosion of its customer base as reliance on third-party IP providers like CEVA is diminished, which could lead to a long-term contraction in both licensing and royalty revenue…"

Do you think there's more to the story for CEVA? Head over to our Community to see what others are saying!

The Bottom Line

CEVA looks undervalued on its tailored P/S framework, yet the broader set of valuation checks still scores the stock weakly, so the overall picture is not straightforwardly cheap. For you, that means the market already prices in a fair amount of optimism around revenue quality and durability, while the cross-checks are less convinced. The real hinge from here is whether CEVA can turn its licensing and royalty pipeline into the kind of consistent revenue that justifies staying on a premium multiple rather than slipping back toward the peer group.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.